By Nicole Hill
Flinn Foundation
Imagine a more efficient pacemaker battery, or a tool to quicken surgery time, or a wearable to track your heart as you begin a new workout. Innovations like these are developed by bioengineers every day.
Bioengineering bridges medicine and technology to develop practical solutions that solve pressing challenges and improve human health and health care.
A partnership between the Flinn Foundation, Arizona State University, and Mayo Clinic will help bioengineers work hand-in-hand with clinicians, patients, and health systems to solve real-world clinical problems.
The Flinn Foundation’s $3.3 million, five-year grant that began in early 2024 will help ASU develop its Division for Medical Engineering, in collaboration with Mayo Clinic. Part of the initiative is a master’s degree program that’s the first of its kind in the state: the Master of Science in Innovations in Medical and Patient Care Technologies, or IMPACT MS.
Applications are being accepted through Friday, June 13.
IMPACT MS is a full-time, three-semester program held in-person on both ASU and Mayo Clinic campuses designed for engineers wanting to grow their careers within the clinical, entrepreneurial, executive, or biomedical industry fields.
Key elements include:
- Hands-on clinical immersion at Mayo Clinic, where students observe real patient care and identify unmet clinical needs.
- Engineering innovation training focused on product design, prototyping, and testing.
- Entrepreneurship and commercialization insights to prepare students to bring solutions to market.
Optimizing highly trained careers like those in bioengineering is key to growth in jobs, wages, and success of startup companies. It also assures well-rounded engineers are at the helm of medical innovation.
Learn more and apply at IMPACT MS.